In the spirit of full disclosure, I'm going public with a humiliating confession. In "Harry Potter and the Prisoner of ...

Social media's age assurance has emerged as one of the most debated topics in trust and safety. In this guest commentary, ...

The U of A researchers who received funding are contributing significant science to projects ranging from smart robotics and lithium batteries to supply chain efficiency and low-friction graphite ...

Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 12.39%, which has investors questioning if this is right time ...

The impairment, often associated with long Covid, doesn’t mean you’re more likely to get dementia or Alzheimer’s disease.

Julie Reiner helped build the cocktail culture we know and love today, and one drink exemplifies her approach.

Explore biomanufacturing with Dr. Doug Friedman and discover how it transforms the global economy and job markets.

Like past innovations, LLMs are sparking a new sense of curiosity and wonder—and it is affecting our language.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a presentation at the 24th Annual Needham Virtual ...

Swiss National Bank increased its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 34.4% during the 4th ...

Lexicon's stock rose 60% after securing a potential $1 billion deal with Novo Nordisk for preclinical obesity drug LX9851.

In the assessment of 12-month price targets, analysts unveil insights for Lexicon Pharmaceuticals, presenting an average ...